Epidarex Capital invests in early-stage, high-growth health science companies in under-ventured markets in the US and in the UK. The firm invests via a two fund structure, including its Bethesda-based fund Rock Spring Ventures and its Edinburgh, Scotland-based fund Rock Spring Ventures EU, respectively. Epidarex's focus is on providing equity capital to young companies including university spin-outs that are currently developing commercial applications of novel research.The firm focuses its investments in growing life sciences, healthcare, healthcare IT, pharmaceuticals, medical devices, and biotechnology industry sectors.
Venture Capital
2 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.